For additional assessment of synergistic effects, tumor cell survival of cell lines A673 and TC32 were analyzed 48hpi and 24h after addition of CHM1 CD8 T cells using SRB assays and the R tool SynergyFinder (42, 43). The gene discussed is CD8A; the disease is neoplasm.